logo
Share SHARE
FONT-SIZE Plus   Neg

Webster Q3 Profit Up, Matches Estimates - Quick Facts

Webster Financial Corp. (WBS), the holding company for Webster Bank, N.A., Friday reported a slight increase in net income for the third quarter, with an increase in net interest income. Earnings per share matched the Street estimates.

Net income available to shareholders was $44.6 million or $0.49 per share, compared with $44.3 million or $0.48 per share during the same quarter last year.

On average, sixteen analysts polled by Thomson Reuters expected earnings per share of $0.49 for the quarter. Analysts' estimates typically exclude one-time items.

Net interest income for the quarter increased to $149.9 million, from prior year's $144.8 million. The Street expected the company to generate revenues of $149.73 million for the quarter.

"Notable milestones in the quarter included record net interest income once again and stellar performance in our health savings account business whose footings crossed $2 billion. Looking ahead, our strong commercial loan pipeline bodes well for the region's economic recovery and future performance." said James Smith, chairman and chief executive officer.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Hyundai Motor America, an official NFL sponsor, is returning to Super Bowl advertising, and planning to shoot a documentary as the game is being played to run in its spot. The reigning 2016 USA Today Super Bowl Ad Meter winner, in a statement on Wednesday, said it will film a 90-second documentary during the game that will capture some of the best off-the-field Super Bowl moments. Consumer Financial Protection Bureau or CFPB filed a lawsuit Wednesday against Navient, the nation's largest student loan company, alleging that it failed borrowers at at every stage of repayment. In response, Navient, in a statement, said the allegations are unfounded, and with political motivations, and rejected CFPB ultimatum to settle by Inauguration Day or be sued. Lilly is all set to acquire CoLucid Pharma for $46.50 per share in cash or approximately $960 million.
comments powered by Disqus
Follow RTT